Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.

Goldaracena N, Gorgen A, Doyle A, Hansen BE, Tomiyama K, Zhang W, Ghanekar A, Lilly L, Cattral M, Galvin Z, Selzner M, Bhat M, Selzner N, McGilvray I, Greig PD, Grant DR, Sapisochin G.

J Hepatol. 2019 Jan 8. pii: S0168-8278(19)30003-0. doi: 10.1016/j.jhep.2018.12.029. [Epub ahead of print]

PMID:
30630009
2.

Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.

Galvin Z, Rajakumar R, Chen E, Adeyi O, Selzner M, Grant D, Sapisochin G, Greig P, Cattral M, McGilvray I, Ghanekar A, Selzner N, Lilly L, Patel K, Bhat M.

Liver Transpl. 2019 Jan;25(1):56-67. doi: 10.1002/lt.25338.

PMID:
30609189
3.

New-Onset Diabetes and Preexisting Diabetes Are Associated With Comparable Reduction in Long-Term Survival After Liver Transplant: A Machine Learning Approach.

Bhat V, Tazari M, Watt KD, Bhat M.

Mayo Clin Proc. 2018 Dec;93(12):1794-1802. doi: 10.1016/j.mayocp.2018.06.020.

PMID:
30522594
4.

Report of the 24th Annual Congress of the International Liver Transplantation Society.

De Martin E, Hessheimer A, Chadha R, Kabacam G, Raganayagam J, Kirchner V, Kalisvaart M, Scalera I, Bhat M, Contreras A, Bhangui P.

Transplantation. 2018 Nov 19. doi: 10.1097/TP.0000000000002549. [Epub ahead of print]

PMID:
30461723
5.

Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome.

Kollmann D, Goldaracena N, Sapisochin G, Linares I, Selzner N, Hansen BE, Bhat M, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M.

Liver Transpl. 2018 Nov;24(11):1512-1522. doi: 10.1002/lt.25197.

PMID:
30264930
6.

Splenectomy as Flow Modulation Strategy and Risk Factors of De Novo Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplantation.

Linares I, Goldaracena N, Rosales R, Maza L, Kaths M, Kollmann D, Echeverri J, Selzner N, McCluskey SA, Sapisochin G, Lilly LB, Greig P, Bhat M, Ghanekar A, Cattral M, McGilvray I, Grant D, Selzner M.

Liver Transpl. 2018 Sep;24(9):1209-1220. doi: 10.1002/lt.25212.

PMID:
30146768
7.

Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.

Bhat M, Mara K, Dierkhising R, Watt KDS.

Mayo Clin Proc. 2018 Sep;93(9):1236-1246. doi: 10.1016/j.mayocp.2018.04.025. Epub 2018 Jul 29.

PMID:
30064826
8.

Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence.

Goldaracena N, Barbas AS, Galante A, Sapisochin G, Al-Adra D, Selzner N, Galvin Z, Cattral MS, Greig PD, Lilly L, Bhat M, McGilvray ID, Ghanekar A, Levy G, Grant DR, Selzner M.

Clin Transplant. 2018 Aug;32(8):e13304. doi: 10.1111/ctr.13304. Epub 2018 Jul 16.

PMID:
29947154
9.

Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.

Kollmann D, Sapisochin G, Goldaracena N, Hansen BE, Rajakumar R, Selzner N, Bhat M, McCluskey S, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M.

Liver Transpl. 2018 Jun;24(6):779-789. doi: 10.1002/lt.25068. Epub 2018 May 14.

10.

Surgical Complications after Right Hepatectomy for Live Liver Donation: Largest Single-Center Western World Experience.

Gorgen A, Goldaracena N, Zhang W, Rosales R, Ghanekar A, Lilly L, Cattral M, Greig P, McCluskey S, McGilvray I, Selzner N, Bhat M, Selzner M, Levy G, Grant D, Sapisochin G.

Semin Liver Dis. 2018 May;38(2):134-144. doi: 10.1055/s-0038-1636932. Epub 2018 Mar 22.

PMID:
29566408
11.

Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis.

Bhat V, Srinathan S, Pasini E, Angeli M, Chen E, Baciu C, Bhat M.

World J Hepatol. 2018 Jan 27;10(1):155-165. doi: 10.4254/wjh.v10.i1.155.

12.

Gender, Race and Disease Etiology Predict De Novo Malignancy Risk After Liver Transplantation: Insights for Future Individualized Cancer Screening Guidance.

Bhat M, Mara K, Dierkhising R, Watt KD.

Transplantation. 2019 Jan;103(1):91-100. doi: 10.1097/TP.0000000000002113.

PMID:
29377876
13.

Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.

Sadler EM, Mehta N, Bhat M, Ghanekar A, Greig PD, Grant DR, Yao F, Sapisochin G.

Transplantation. 2018 Apr;102(4):640-647. doi: 10.1097/TP.0000000000002043.

PMID:
29319620
14.

Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.

Baciu C, Pasini E, Angeli M, Schwenger K, Afrin J, Humar A, Fischer S, Patel K, Allard J, Bhat M.

PLoS One. 2017 Dec 7;12(12):e0189223. doi: 10.1371/journal.pone.0189223. eCollection 2017.

15.

Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis.

Bhat M, Tazari M, Sebastiani G.

PLoS One. 2017 Sep 27;12(9):e0185192. doi: 10.1371/journal.pone.0185192. eCollection 2017.

16.

Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.

Aravinthan AD, Barbas AS, Doyle AC, Tazari M, Sapisochin G, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Greig PD, Bhat M, Selzner N, Grant DR, Lilly LB, Renner EL.

Transpl Int. 2017 Nov;30(11):1140-1149. doi: 10.1111/tri.13008. Epub 2017 Jul 27.

17.

Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience.

Barbas AS, Goldaracena N, Dib MJ, Al-Adra DP, Aravinthan AD, Lilly LB, Renner EL, Selzner N, Bhat M, Cattral MS, Ghanekar A, McGilvray ID, Sapisochin G, Selzner M, Greig PD, Grant DR.

Transplant Direct. 2017 May 10;3(6):e158. doi: 10.1097/TXD.0000000000000674. eCollection 2017 Jun.

18.

Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.

Kumar D, Patil N, Husain S, Chaparro C, Bhat M, Kim SJ, Humar A.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.13000. Epub 2017 Jun 1.

PMID:
28489256
19.

Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients.

Bhat M, Rollet-Kurhajec KC, Bhat A, Farag A, Deschenes M, Wong P, Ghali P, Sebastiani G.

Can J Gastroenterol Hepatol. 2017;2017:4381864. doi: 10.1155/2017/4381864. Epub 2017 Mar 19.

20.

Reply to: "Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?"

Bhat M, Ghali P, Bilodeau M.

J Hepatol. 2017 Jul;67(1):199-200. doi: 10.1016/j.jhep.2017.03.019. Epub 2017 Mar 24. No abstract available.

PMID:
28347800

Supplemental Content

Loading ...
Support Center